← boothcheck

CNC vs MOH stock comparison

CENTENE CORPORATION vs MOLINA HEALTHCARE, INC., two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Both Medicaid managed-care margins have collapsed, and the pair is about which collapse is worse: Centene's net margin sits at negative 3.3%, Molina's clings to positive 0.42%, neither with a usable earnings multiple this year. The industry's mechanism failed both the same way, state rate resets lagging post-pandemic medical costs. Scale separates them, $33B against $12B of market value, and posture: Centene's 21.8% free-cash figure is float against future claims, not comfort. Returns on equity, negative 30% against positive 4.6%, say Centene took the bigger writedowns. These are two recovery bets on the same regulatory cycle; the prices assume the states eventually pay actuarially sound rates, and the timing is the entire risk.

Comparison updated 2026-07-10.

CNC vs MOH: the numbers

MetricCNCMOH
Price$65.73$229.88
Market cap$32.6B$11.7B
SectorManaged CareManaged Care
StageGrowthMature
P/B1.512.87
P/S0.160.26
EV/EBITDA16.5
Revenue growth+17.4%+8.0%
Gross margin11.3%
Operating margin3.7%0.8%
Net margin-3.3%0.4%
Return on equity-30.0%4.6%
Return on assets-7.9%1.1%
Return on invested capital-14.1%2.6%
FCF yield21.8%2.1%
Debt / equity0.760.92
Current ratio1.121.63
Altman Z (solvency)3.094.02
Piotroski F (quality)6 / 97 / 9
Full CNC report → Full MOH report →
Get boothcheck's read on CNC and MOH, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.